Merited Wealth’s Abbott ABT Stock Holding History

Merited Wealth’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-119	Closed	-$14.9K	–	81
2025 Q4	$14.9K	Buy	+119	New	+$15.2K	0.01%	180

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Merited Wealth's ABT Position: Q1 2026 in Review

Merited Wealth sold out of Abbott (ABT) in Q1 2026, closing a stake of 119 shares — an estimated $14.9K sold.

Merited Wealth first reported a position in ABT in Q4 2025 and held it in 1 quarter. The position peaked at $14.9K in Q4 2025. 3,106 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Merited Wealth reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
Merited Wealth sold 119 Abbott shares in Q1 2026, an estimated $14.9K.
Merited Wealth first reported a position in Abbott in Q4 2025 and held it in 1 quarter.
Merited Wealth's Abbott position peaked at $14.9K in Q4 2025.
3,106 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Merited Wealth's 13F filing for Q1 2026, filed 24 Apr 2026.